DURHAM, N.C.--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s cochlear implant system for single-sided deafness (SSD) and ...

The cochlear implant systems that we know today with small designs and built-in future-ready technology have come a long way since Austrian scientists Ingeborg and Erwin Hochmair began working on ...

Existing treatment options, which include hearing aids or bone conduction devices, often fail to address these issues because they generally only serve to reroute sound signals from one ear to the ...

The company is in the final stages of finding larger office space. Thanks in large part to early success of its next-generation cochlear implant, MED-EL CEO Ray Gamble says he expects to increase ...